Pharmaceutical composition for immunomodulating and adjuvant treatment
AssigneeAliatros Medical, a.s.
InventorOlga Kufudaki
Life of this patent
Estimating the term…
Abstract
Pharmaceutical composition for immunomodulating and adjuvant therapy containing a metabolic stressor, 2-deoxy-D-ribose and further active components, i.e. ribose, DL-alanine, nicotonic acid, L-ascorbic acid, thiamin and glutamic acid amide is intended for immunomodulating and adjuvant therapy and for prevention of weakening of the immunity system.
Claims21
A pharmaceutical composition for immunomodulating and adjuvant treatment comprising:
- (a) a D-ribose in an amount ranging from about 32 to 63 wt %, (b) a deoxy-derivative of a D-monosaccharide in an amount ranging from about 32 to 63 wt % (c) DL-alpha-alanine in amount ranging from about 6 to 29 wt %, (d) nicotinic acid in an amount ranging from about 6 to 24 wt %, and (e) L-ascorbic acid ranging from about 22 to 45 wt % %, based on the total weight % of the composition.
A method for stimulating the production of cytokines in a patient by intravenous application of a composition dissolved in physiological saline, said composition comprising:
- (a) a D-ribose in an amount ranging from about 32 to 63 wt %,
- (b) a deoxy-derivative of a D-monosaccharide in an amount ranging from about 32 to 63 wt %
- (c) DLalpha-alanine in amount ranging from about 6 to 29 wt %,
- (d) nicotinic acid in an amount ranging from about 6 to 24 wt %, and
- (e) L-ascorbic acid ranging from about 22 to 45 wt % %, based on the total weight % of the composition.
A pharmaceutical composition for immunomodulating and adjuvant treatment made by combining:
- (a) a D-ribose in an amount ranging from about 32 to 63 wt %, (b) a deoxy-derivative of a D-monosaccharide in an amount ranging from about 32 to 63 wt % (c) DL-alpha-alanine in amount ranging from about 6 to 29 wt %, (d) nicotinic acid in an amount ranging from about 6 to 24 wt %, and (e) L-ascorbic acid ranging from about 22to 45 wt % %, based on the total weight % of the composition.
A method for stimulating the production of cytokines in a patient by intravenous application of a composition capable of being dissolved dissolved in physiological saline, said composition made by combining:
- (a) a D-ribose in an amount ranging from about 32 to 63 wt %,
- (b) a deoxy-derivative of a D-monosaccharide in an amount ranging from about 32 to 63 wt %,
- (c) DL-alpha-alanine in amount ranging from about 6 to 29 wt %,
- (d) nicotinic acid in an amount ranging from about 6 to 24 wt %, and
- (e) L-ascorbic acid ranging from about 22 to 45 wt % %, based on the total weight % of the composition.
Dependencies are inferred from the claim text.